5 day volume Average = 4,442,800
20 day volume Average = 2,316,510
90 day volume Average = 3,520,404
Add to wishlistAdded to wishlistRemoved from wishlist 2
Add to compare
4.5/10 (Expert Score)
Product is rated as #151 in category BM Industrial Products & Services
PROS:
  • Cash Rich Company
  • High Trading Liquidity
CONS:
  • No Dividend Declared
  • Low Price-to-Tangible ratio

klse: Ho Wah Genting Bhd


Corporate Information

Board   : Main

Shariah : Shariah Compliant

Sector   : Electrical Product Electronic Device

Address: Wisma Ho Wah Genting,1st Floor, No. 35
, Jalan Maharajalela, 50150, Kuala Lumpur

Contact: +603-21438811

Website: https://www.hwgenting.com.my/
 

Corporate Background

Ho Wah Genting Berhad is an investment holding company. The Company, through its subsidiaries, manufactures wires, cables, molded power supply cord sets, and cable assemblies for electrical and electronic devices and equipment.

Specification: HWGB 9601

Market Capital (RM) 79, 509, 347
Forecasted Profit or Loss (RM) 2, 852, 296
Estimated Future EPS (sen) 0.43
Perspective P/E ratio 27.876
Estimated Dividend Yield (%) 0
Adjusted NTA (RM) 0.13

Result

Quarter Report History

DateRevenue,kPBT,kNet Profit,k
20/12/22108,4982,0791,428
28/09/22145,2354,4973,175
28/06/2295,594-4,485-4,500
25/03/22114,4561,9321,022
23/12/21121,165-669-1,266
29/09/21119,887-175-689
25/06/2125,124-1,048-983
25/05/2178,936-8,341-8,423
24/02/2190,527-21,227-20,924
26/11/2096,0922-773
27/08/2053,267-1,699-1,869
28/05/2048,1751,9541,169

Fundamental

Fundamental Analysis

Last 4 Quarter Revenue (RM’000)463,783
Last 4 Quarter Net Profit (RM’000)1,070
Last 4 Quarter EPS (sen)0.17
Last 4 Quarter PER74.31
Last 4 Quarter Dividend (sen)
Last 4 Quarter Dividend Yield (%)
Net Tangible Assets (RM)0.11
Goodwill (RM)410
Cash (RM’000)30,460
Debt (RM’000)5,130
Total Debt (RM’000)41,660
Net Assets (RM’000)84,050
Current Ratio1.48
Quick Ratio0.33
Cash Ratio0.15

Technical

Technical Analysis

MACD (26 vs 12)0.001
Exponential Moving Average 50.122
Exponential Moving Average 200.118
Exponential Moving Average 900.119
Relative Strength Index 140.71
Stochastic %D 30.72
Stochastic %K 140.75

Shareholders

Top 30 Shareholders

Shareholder NameFinancial YearNumber (Ratio)
M & A Nominee (Tempatan) Sdn Bhd Pledged Securities Account For Ho Wah Genting Holding Sdn Bhd (M&A) 202148,500,000 (7.830)
Ho Wah Genting Holding Sdn Bhd 202130,155,200 (4.870)
UOB Kay Hian Nominees (Asing) Sdn Bhd Exempt An For UOB Kay Hian Pte Ltd ( A/C Clients ) 202128,058,350 (4.530)
Ho Wah Genting Holding Sdn Bhd 202117,134,000 (2.770)
UOB Kay Hian Nominees (Tempatan) Sdn Bhd Exempt An For UOB Kay Hian Pte Ltd ( A/C Clients ) 202112,142,000 (1.960)
Kenanga Nominees (Tempatan) Sdn Bhd Rakuten Trade Sdn Bhd For Law Peck Hsia 202110,941,500 (1.770)
Ho Wah Genting Holding Sdn Bhd 202110,000,000 (1.610)
Maybank Nominees (Tempatan) Sdn Bhd Pledged Securities Account For Tee Tiam Hock 20217,648,000 (1.230)
Dk Leather Seats Sdn. Bhd. 20217,548,000 (1.220)
Ooi Thean Boon 20213,456,200 (0.560)
Tan Kok Leong 20213,410,000 (0.550)
RHB Nominees (Tempatan) Sdn Bhd Pledged Securities Account For Tee Tiam Hock 20213,364,000 (0.540)
Ch’ng Joo Nee 20212,995,000 (0.480)
M & A Nominee (Tempatan) Sdn Bhd For Ho Wah Genting Holding Sdn Bhd 20212,861,865 (0.460)
Yew Hoo Yong 20212,556,000 (0.410)
Lim Sing Yee 20212,508,000 (0.400)
Yap Su Ling 20212,400,000 (0.390)
Tai Thong Ming 20212,324,500 (0.380)
Ooi Bee Lian 20212,200,000 (0.360)
Lawrence Chua Sue Lin 20212,193,000 (0.350)
Public Nominees (Tempatan) Sdn Bhd Pledged Securities Account For Cheng Lin Chin (E-Bpt) 20211,786,500 (0.290)
Tan Kok Seong 20211,700,000 (0.270)
Aw Keong Leong 20211,645,000 (0.270)
Teo Tiew 20211,581,325 (0.260)
Lai Kim Lan 20211,533,000 (0.250)
Kenanga Nominees (Tempatan) Sdn Bhd Rakuten Trade Sdn Bhd For Yeong Jong Luun 20211,530,700 (0.250)
Yim Chun Toong 20211,503,800 (0.240)
Loh Kah Hock 20211,500,000 (0.240)
Chin Chiew Ted 20211,450,000 (0.230)
Chu Wan Chek 20211,436,000 (0.230)

15 reviews for HWGB 9601

2.0 out of 5
0
0
3
2
3
Write a review
Show all Most Helpful Highest Rating Lowest Rating
  1. BURSA MALAYSIA

    BURSA MALAYSIA

    The Group recorded a lower revenue of RM95.59 million (3Q 2022: RM114.46 million) a decrease of RM18.87 million or 16.5%. The lower revenue was due to low season. The Group recorded a loss before taxation of RM4.50 million (3Q 2022: profit before taxation of RM1.93 million) in the current quarter

    Helpful(0) Unhelpful(0)You have already voted this
  2. Avatar

    The Edge

    Ho Wah Genting Bhd and its wholly-owned subsidiary, HWGB EV Sdn Bhd (HWGB EV), have undertaken several strategic moves together with its partners towards the introduction of electric vehicles (EV) in Malaysia. HWGB said that it has entered into separate MOU with Seiyong Motor Co Ltd, Xiamen Chief Electric Vehicle Co Ltd and Beijing Aitou Capital Management Ltd (AiTou) for the purpose of introducing electric vehicles in Malaysia.

    Helpful(0) Unhelpful(0)You have already voted this
  3. Avatar

    The Edge

    Ho Wah Genting Berhad, through its wholly-owned subsidiary HWGB Biotech Sdn Bhd has been successfully granted the Pharmacist’s Poisons Licence (Type A License) from the Pharmaceutical Services Division of Ministry of Health Malaysia which enable the Company to import, store and deal generally by wholesale all controlled medicine.

    Helpful(0) Unhelpful(0)You have already voted this
  4. Avatar

    The Star

    Ho Wah Genting Bhd has obtained a full pharmaceutical product registration approval for its wholly-owned subsidiary, Astramern Sdn Bhd’s health supplement, Astramern Astra H, from the National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health. The NPRA’s full approval for the health supplement and traditional medicine is granted for the maximum period of five years and renewable thereof, it said in a statement here today.

    Helpful(0) Unhelpful(0)You have already voted this
  5. Avatar

    The Edge

    Ho Wah Genting Bhd is planning to raise up to RM34.58 million via a private placement. The group said it would be placing up to 60.67 million new shares, representing 10% of its share capital of 606.68 million shares, among third-party investors. Ho Wah Genting plans to use up to RM12 million of the placement proceeds to purchase healthcare products and for research and development activities for its healthcare-related business. Another RM10 million would be used to fully repay a loan from Hong Kong-based Prime King Investment Ltd. Up to RM11.77 million of the proceeds would be used for general working capital requirements.

    Helpful(0) Unhelpful(0)You have already voted this
  6. Avatar

    The Edge

    Ho Wah Genting Bhd’s share price declined 22% to 69 sen from 89 sen between Dec 7 and 14. Chinese national Zhang Yong, through ZY Sales & Distribution Sdn Bhd, ceased to be a substantial shareholder of HWG after disposing of his entire stake on the open market. It was only in October that Zhang emerged as a shareholder of HWG through ZY Sales & Distribution after acquiring 90 million shares or a 17.09% stake. HWG, which started the year as a penny stock trading at 11 sen, hit a high of RM1.29 on Aug 11 on speculative fervour surrounding the Covid-19 theme, but has been on a decline since.

    Helpful(0) Unhelpful(0)You have already voted this
  7. Avatar

    The Edge

    Ho Wah Genting Bhd said its wholly-owned subsidiary has obtained a one-year conditional approval from Indonesia’s health ministry to manufacture medical products such as surgical face masks, Covid-19 rapid test cassettes and liquid chemical sterilants.

    Helpful(0) Unhelpful(0)You have already voted this
  8. Avatar

    The Star

    US-based E-MO Biology Inc, the joint-venture partner of Ho Wah Genting Bhd’s wholly-owned subsidiary, HWGB Biotech Sdn Bhd, has obtained approval from the US Food and Drug Administration (FDA) to conduct phase IV clinical trials for a vaccine against Covid-19. In a statement, HWGB said HWGB Biotech would invest US$1mil (RM4.16mil) and would be entitled to 40% of the total net profit. With the FDA approval, HWGB chief executive officer Datuk Aaron Lim said the repurposing of the proven polio virus vaccines could fast track the Covid-19 vaccine development to save lives

    Helpful(0) Unhelpful(0)You have already voted this
  9. Avatar

    The Edge

    A report that Malaysia will be a priority recipient of China’s COVID-19 vaccine bodes well for the pharmaceutical counters and companies which had secured the vaccine deals. Ho Wah Genting, of which its wholly-owned subsidiary, HWGB Biotech Sdn Bhd entered into a Memorandum of Understanding (MoU) with Xinkexian (Beijing) Biotechnology Co, Ltd (XKX) last month to consider appointing XKX as its non-exclusive manufacturer to produce COVID-19 vaccines, also improved 10 sen to 74 sen.

    Helpful(0) Unhelpful(0)You have already voted this
  10. Avatar

    The Edge

    The company has been on investors’ radar screens since the coronavirus outbreak, initially over the distribution of Covid-19 test kits. However, it upped its game in August when it declared that it was officially in the race to produce a vaccine. However, there is scepticism over whether its ventures will succeed. Leinves PLT chief investment officer William Ng expresses doubts over HWGB’s plan to produce Covid-19 vaccines. He says HWGB does not have an established track record in the pharmaceutical industry

    Helpful(0) Unhelpful(0)You have already voted this
  11. Avatar

    The Edge

    HWGB’s joint venture partner, US-based E-MO Biology Inc (EBI), has entered into three research and development (R&D) agreements to produce COVID-19 vaccines.

    Helpful(0) Unhelpful(0)You have already voted this
  12. BURSA MALAYSIA

    BURSA MALAYSIA

    The Group’s revenue for the current quarter increased by RM5.09 million or 10.6% compared to its immediate preceding quarter. The higher revenue in the current quarter was due to higher demand from existing customers.

    Helpful(0) Unhelpful(0)You have already voted this
  13. REMUNERATION STUDY

    REMUNERATION STUDY

    In Financial Year End 2019, the directors’ remuneration was 1.34 million. It was fair compared to average in listed companies, considering the employees’ remuneration of 21.2 million and auditor’s remuneration of 125 thousands

    Helpful(0) Unhelpful(0)You have already voted this
  14. BURSA MALAYSIA

    BURSA MALAYSIA

    The Group’s revenue for the current quarter increased by RM13.79 million or 40.1% compared to its preceding quarter. The higher revenue was due to higher demand from existing customers. The Group recorded a PBT of RM1.95 million in the current quarter as compared to a LBT of RM5.60 million in the preceding quarter. The higher LBT was mainly due to an allowance of expected credit loss on amount due from an associate of RM4.00 million and lower profit generated from the Group’s lower revenue recorded.

    Helpful(1) Unhelpful(0)You have already voted this
  15. Avatar

    Investing Malaysia

    Average investing volume for Ho Wah Genting Bhd in the past three months in stock market was 1171.2k lots

    Helpful(0) Unhelpful(0)You have already voted this
  16. Avatar

    Investing Malaysia

    HWGB gets a score of 6.55 in our equity and assets quality test based on current share price of RM0.12

    Helpful(0) Unhelpful(0)You have already voted this
  17. Avatar

    Investing Malaysia

    Ho Wah Genting Bhd gets a score of 8.31 in our stability test after the balance sheet, money statement study

    Helpful(0) Unhelpful(0)You have already voted this
  18. Avatar

    Investing Malaysia

    Stock code of 9601 in Bursa Malaysia did not propose any dividend for the past few years

    Helpful(0) Unhelpful(0)You have already voted this
  19. Avatar

    Investing Malaysia

    HWGB is forecasted to made loss of 2.31 millions, with an adjusted market capitalization of 56.09 millions

    Helpful(0) Unhelpful(0)You have already voted this
  20. REMUNERATION STUDY

    REMUNERATION STUDY

    In Financial Year End 2018, the directors’ remuneration was 1.57 million. It was fair compared to average in listed companies, considering the employees’ remuneration of 19.2 million and auditor’s remuneration of 126 thousands

    Helpful(0) Unhelpful(0)You have already voted this

    Add a review

    Your email address will not be published. Required fields are marked *

    All search results
    klse investing
    Logo
    Enable registration in settings - general
    Compare items
    • Total (0)
    Compare